Figure 4.
Brief hyperoxic exposure decreased muscle sympathetic activity (MSNA) in all treatment groups. Within the losartan group, the amount of hyperoxic inhibition of total MSNA activity was diminished significantly after 6 weeks of treatment, but this change wasn’t statistically different from changes in the allopurinol or placebo group (RM-ANOVA p>0.05). Data shown are mean±SEM.